ArticleRheumatology and therapy2023

Ixekizumab Efficacy in Patients with Severe Peripheral Psoriatic Arthritis: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (SPIRIT-P1).

Hideto Kameda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.